The incretin effect is well documented to be impaired in patients with T2DM with the primary defect lying at the level of beta cells [5], but impaired GLP-1 secretion from L-cells is also a major contributory factor [6]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.